Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Endovia Health Sciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +1 vs. Q3 2022
- Shares held
- 2.28M
- +213.1K (+10.3%) vs. Q3 2022
- Total value
- $2.19M
- −$643.5K (−22.7%) vs. Q3 2022
- New holders
- 5
- 8 more added
- Sold out
- 4
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,257,887 | $1.21M | 0.00% | +122,482+10.8% | Added |
| Geode Capital Management, LLC | 223,120 | $214.0K | 0.00% | +8,621+4.0% | Added |
| Citadel Advisors LLC | 214,529 | $206.2K | 0.00% | +135,209+170.5% | Added |
| Bridgeway Capital Management, LLC | 102,300 | $98.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 79,573 | $76.5K | 0.00% | +79,573 | New |
| State Street Corp | 70,000 | $67.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 62,409 | $60.0K | 0.00% | +1,340+2.2% | Added |
| Northern Trust Corp | 42,618 | $41.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 41,495 | $40.0K | 0.01% | −29,527−41.6% | Reduced |
| Parsons Capital Management Inc | 33,249 | $32.0K | 0.00% | −100,002−75.0% | Reduced |
| Sabby Management, LLC | 28,255 | $27.2K | 0.07% | +7,000+32.9% | Added |
| Cambridge Investment Research Advisors, Inc. | 24,264 | $23.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 16,852 | $16.2K | 0.00% | +4,651+38.1% | Added |
| Millennium Management LLC | 15,533 | $15.0K | 0.00% | +15,533 | New |
| StoneX Group Inc. | 14,300 | $13.7K | 0.00% | +14,300 | New |
| Bank of New York Mellon Corp | 11,709 | $11.3K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 10,630 | $10.6K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,090 | $9.00K | 0.00% | −6,510−41.7% | Reduced |
| Cutler Group LP | 10,360 | $9.00K | 0.00% | +10,360 | New |
| UBS Group AG | 8,006 | $7.69K | 0.00% | +7,195+887.2% | Added |
| Simplex Trading, LLC | 2,269 | $2.00K | 0.00% | −11,576−83.6% | Reduced |
| Wells Fargo & Company | 196 | $188 | 0.00% | +21+12.0% | Added |
| Bank of America Corp | 37 | $36 | 0.00% | +37 | New |
| FMR LLC | 5 | $5 | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −30,044−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −15,343−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |